| User's Publication |
|
21610
Kaneda-Nakashima K, Shirakami Y, Kadonaga Y, Watabe T, Ooe K, Yin X, Haba H, Shirasaki K, Kikunaga H, Tsukada K, Toyoshima A, Cardinale J, Giesel FL, Fukase K.
Comparison of Nuclear Medicine Therapeutics Targeting PSMA among Alpha-Emitting Nuclides.
Int J Mol Sci
2024
25(2)
PubMed ID: 38256007
DOI: 10.3390/ijms25020933
|
|
21737
Shiomi A, Kaneko T, Nishikawa K, Tsuchida A, Isoshima T, Sato M, Toyooka K, Doi K, Nishikii H, Shintaku H.
High-throughput mechanical phenotyping and transcriptomics of single cells.
Nat Commun
2024
15(1):3812
PubMed ID: 38760380
DOI: 10.1038/s41467-024-48088-5
|
|
22335
Oike T, Kambe R, Darwis NDM, Shibata A, Ohno T.
Establishment of cancer cell radiosensitivity database linked to multi-layer omics data
Cancer Sci
2024
2024 Dec 12
PubMed ID: 39668120
DOI: 10.1111/cas.16334
|
|
19646
Ohya S, Kajikuri J, Kito H, Matsui M.
Down-Regulation of CYP3A4 by the KCa1.1 Inhibition Is Responsible for Overcoming Resistance to Doxorubicin in Cancer Spheroid Models
Int J Mol Sci
2023
24(21):15672
PubMed ID: 37958656
DOI: 10.3390/ijms242115672
|
|
19764
Yamashita SN, Tanaka Y, Kitagawa T, Baron B, Tokuda K, Paudel D, Nakagawa K, Ohta T, Hamada JI, Kobayashi M, Nagayasu H, Kuramitsu Y.
Down-regulating Effect of a Standardized Extract of Cultured Lentinula edodes mycelia on Cortactin in Prostate Cancer Cells Is Dependent on Malignant Potential
Anticancer Res
2023
43(3):1159-1166
PubMed ID: 36854514
DOI: 10.21873/anticanres.16261
|
|
21021
Hayashi Y, Kimura S, Yano E, Yoshimoto S, Saeki A, Yasukochi A, Hatakeyama Y, Moriyama M, Nakamura S, Jimi E, Kawakubo-Yasukochi T.
Id4 modulates salivary gland homeostasis and its expression is downregulated in IgG4-related disease via miR-486-5p.
Biochim Biophys Acta Mol Cell Res
2023
1870(2):119404
PubMed ID: 36535369
DOI: 10.1016/j.bbamcr.2022.119404
|
|
21112
Chingle RM, Imai M, Altman S, Saito D, Takahashi N, Burke TR.
Examination of aminophenol-containing compounds designed as antiproliferative agents and potential atypical retinoids.
Bioorg Med Chem
2023
82:117214
PubMed ID: 36913882
DOI: 10.1016/j.bmc.2023.117214
|
|
17648
Viet Hung T, Thang PNT, Hien HM, Diep VT, Thu NT, Tan DM, Pham DT, Thi Ha D, Huynh DTM.
Cytotoxic Activities and Fingerprint Analysis of Triterpenes by HPTLC Technique for Distinguishing Ganoderma Species from Vietnam and other Asian Countries
Plants (Basel)
2022
11(23):3397
PubMed ID: 36501435
DOI: 10.3390/plants11233397
|
|
17655
Ohya S, Matsui M, Kajikuri J, Kito H, Endo K.
Downregulation of IL-8 and IL-10 by the Activation of Ca2+-Activated K+ Channel KCa3.1 in THP-1-Derived M2 Macrophages
Int J Mol Sci
2022
23(15):8603
PubMed ID: 35955737
DOI: 10.3390/ijms23158603
|
|
18229
Ito S, Ueda T, Yokoyama A, Fujihara A, Hongo F, Ukimura O.
PCA3 controls chromatin organization and p53 signal activation by regulating LAP2α-lamin A complexes
Cancer Gene Ther
2022
29(3-4):358-368
PubMed ID: 33758375
DOI: 10.1038/s41417-021-00314-8
|
|
20582
Qian Y, Liu X, Feng Y, Li X, Xuan Y.
Tenascin C regulates cancer cell glycolysis and tumor progression in prostate cancer.
Int J Urol
2022
PubMed ID: 35218089
DOI: 10.1111/iju.14830
|
|
20668
Mitani F, Lin J, Sakamoto T, Uehara R, Hikita T, Yoshida T, Setiawan A, Arai M, Oneyama C.
Asteltoxin inhibits extracellular vesicle production through AMPK/mTOR-mediated activation of lysosome function.
Sci Rep
2022
12(1):6674
PubMed ID: 35461323
DOI: 10.1038/s41598-022-10692-0
|
|
16725
Hasegawa T, Ito M, Hasegawa S, Teranishi M, Takeda K, Negishi S, Nishiwaki H, Takeda JI, LeBaron TW, Ohno K.
Molecular Hydrogen Enhances Proliferation of Cancer Cells That Exhibit Potent Mitochondrial Unfolded Protein Response
Int J Mol Sci
2022
23(5):2888
PubMed ID: 35270030
DOI: 10.3390/ijms23052888
|
|
16730
Takagi H, Moyama C, Taniguchi K, Ando K, Matsuda R, Ando S, Ii H, Kageyama S, Kawauchi A, Chouha N, Désaubry L, Nakata S.
Fluorizoline Blocks the Interaction between Prohibitin-2 and γ-Glutamylcyclotransferase and Induces p21 Waf1/Cip1 Expression in MCF7 Breast Cancer Cells
Mol Pharmacol
2022
101(2):78-86
PubMed ID: 34862308
DOI: 10.1124/molpharm.121.000334
|
|
16741
Isaac Kingsley Amponsah, Gina Flor Ramos, Benjamin Kingsley Harley, Joseph Adusei Sarkodie, Edmund Ekuadzi, Elikplim Kwesi Ampofo, Inemesit Okon Ben
Anti-inflammatory, Antioxidant and Cytotoxic Activities of Guibourtia ehie on Human Prostate (PC-3) and Breast Cancer (MC-7) Cell Lines and in silico Studies on Its Metabolite 7,4′-Dihydroxyflavone
Chemistry Africa
2022
5:627-639
DOI: 10.1007/s42250-022-00359-8
|
|
16833
Tanaka Y, Kambayashi H, Yamamoto A, Onishi I, Sugita K, Matsumura M, Ishibashi S, Ikeda M, Yamamoto K, Kitagawa M, Kurata M.
Efficient Identification of the MYC Regulator with the Use of the CRISPR Library and Context-Matched Database Screenings
Int J Mol Sci
2022
23(14):7723
PubMed ID: 35887071
DOI: 10.3390/ijms23147723
|
|
17315
Watabe T, Kaneda-Nakashima K, Shirakami Y, Kadonaga Y, Ooe K, Wang Y, Haba H, Toyoshima A, Cardinale J, Giesel FL, Tomiyama N, Fukase K.
Targeted α-therapy using astatine (211At)-labeled PSMA1, 5, and 6: a preclinical evaluation as a novel compound
Eur J Nucl Med Mol Imaging
2022
Nov 8
PubMed ID: 36344651
DOI: 10.1007/s00259-022-06016-z
|
|
13130
Sasaki K, Harada M, Yoshikawa T, Tagawa H, Harada Y, Yonemitsu Y, Ryujin T, Kishimura A, Mori T, Katayama Y.
Fc-Binding Antibody-Recruiting Molecules Targeting Prostate-Specific Membrane Antigen: Defucosylation of Antibody for Efficacy Improvement*.
Chembiochem
2021
22(3):496-500
PubMed ID: 32969164
DOI: 10.1002/cbic.202000577
|
|
13395
Imamura R, Kitagawa S, Kubo T, Irie A, Kariu T, Yoneda M, Kamba T, Imamura T.
Prostate cancer C5a receptor expression and augmentation of cancer cell proliferation, invasion, and PD-L1 expression by C5a.
Prostate
2021
PubMed ID: 33368414
DOI: 10.1002/pros.24090
|
|
20153
Yin X, Yamada S, Kobayashi H, Tanaka R, Togo Y, Hosoi M, Tsuchida M, Kunoh T, Wada S, Nakamura T, Sasaki R, Mizukami T, Hasegawa M.
Expression and cell transformation activity of dynactin-associated protein isoforms.
FEBS Open Bio
2021
PubMed ID: 34043884
DOI: 10.1002/2211-5463.13202
|
|
20249
Makise M, Uchimura R, Higashi K, Mashiki Y, Shiraishi R, Shutoku Y, Kuniyasu A.
Overexpression of the nucleoporin Nup88 stimulates migration and invasion of HeLa cells.
Histochem Cell Biol
2021
PubMed ID: 34331103
DOI: 10.1007/s00418-021-02020-w
|
|
16701
Chinen T, Yamazaki K, Hashimoto K, Fujii K, Watanabe K, Takeda Y, Yamamoto S, Nozaki Y, Tsuchiya Y, Takao D, Kitagawa D.
Centriole and PCM cooperatively recruit CEP192 to spindle poles to promote bipolar spindle assembly
J Cell Biol
2021
220(2):e202006085
PubMed ID: 33443571
DOI: 10.1083/jcb.202006085
|
|
17030
Uwada J, Mukai S, Terada N, Nakazawa H, Islam MS, Nagai T, Fujii M, Yamasaki K, Taniguchi T, Kamoto T, Yazawa T.
Pleiotropic effects of probenecid on three-dimensional cultures of prostate cancer cells
Life Sci
2021
278:119554
PubMed ID: 33932444
DOI: 10.1016/j.lfs.2021.119554
|
|
17032
Kazuko KANEDA-NAKASHIMA, Zijian ZHANG, Kojiro NAGATA, Kenji SHIRASAKI, Hidetoshi KIKUNAGA, Tomoo YAMAMURA, Kazuhiro OOE, Tadashi WATABE, Atsushi TOYOSHIMA, Takashi YOSHIMURA, Atsushi SHINOHARA
Dispersion of Alpha-Nuclides during Animal Experiments
Radiation Safety Management
2021
20:29-38
DOI: 10.12950/rsm.210519
|
|
19498
Kohno S, Linn P, Nagatani N, Watanabe Y, Kumar S, Soga T, Takahashi C.
Pharmacologically targetable vulnerability in prostate cancer carrying RB1-SUCLA2 deletion
Oncogene
2020
39(34):5690-5707
PubMed ID: 32694611
DOI: 10.1038/s41388-020-1381-6
|
|
9833
Keiichi Oono, Kazuo Ohtake, Chie Watanabe, Sachiko Shiba, Takashi Sekiya, Keizo Kasono
Contribution of Pyk2 Pathway and Reactive Oxygen Species (ROS) to the Anti-Cancer Effects of Eicosapentaenoic Acid (EPA) in PC3 Prostate Cancer Cells
Lipids Health Dis
2020
19(1):15
PubMed ID: 32005121
DOI: 10.1186/s12944-019-1122-4
|
|
12088
Nagasawa M, Tomimatsu K, Terada K, Kondo K, Miyazaki K, Miyazaki M, Motooka D, Okuzaki D, Yoshida T, Kageyama S, Kawamoto H, Kawauchi A, Agata Y.
Long non-coding RNA MANCR is a target of BET bromodomain protein BRD4 and plays a critical role in cellular migration and invasion abilities of prostate cancer.
Biochem. Biophys. Res. Commun.
2020
PubMed ID: 32199616
DOI: 10.1016/j.bbrc.2020.03.043
|
|
12152
Shogo Nomura, Yasuko Egawa, Sayaka Urano, Tsuyoshi Tahara, Yasuyoshi Watanabe & Katsunori Tanaka
Cancer discrimination by on-cell N-glycan ligation
Communications Chemistry
2020
PubMed ID: 36703447
DOI: 10.1038/s42004-020-0270-9
|
|
10510
Kenward Vong, Tomoya Yamamoto, Tsung-che Changa and Katsunori Tanaka
Bioorthogonal release of anticancer drugs via gold-triggered 2-alkynylbenzamide cyclization
Chemical Science
2020
11:10928-10933
PubMed ID: 34094342
DOI: 10.1039/D0SC04329J
|
|
13198
Hiromi I, Nakata S, Uenishi J.
Up-regulation of Death Receptor 5/TRAIL-R2 Mediates Apoptosis Induced by N,N'-[(3,4-dimethoxyphenyl)methylene] Biscinnamide in Cancer Cells.
Anticancer Res
2020
PubMed ID: 32878791
DOI: 10.21873/anticanres.14506
|
|
13264
Hikita T, Miyata M, Watanabe R, Oneyama C.
In vivo imaging of long-term accumulation of cancer-derived exosomes using a BRET-based reporter.
Sci Rep
2020
PubMed ID: 33024173
DOI: 10.1038/s41598-020-73580-5
|
|
13303
Uwada J, Nakazawa H, Mikami D, Islam MS, Muramatsu I, Taniguchi T, Yazawa T.
PNU-120596, a positive allosteric modulator of α7 nicotinic acetylcholine receptor, directly inhibits p38 MAPK.
Biochem Pharmacol
2020
PubMed ID: 33132165
DOI: 10.1016/j.bcp.2020.114297
|
|
13317
Fujita K, Kamiya M, Yoshioka T, Ogasawara A, Hino R, Kojima R, Ueo H, Urano Y.
Rapid and Accurate Visualization of Breast Tumors with a Fluorescent Probe Targeting α-Mannosidase 2C1.
ACS Cent Sci
2020
PubMed ID: 33376783
DOI: 10.1021/acscentsci.0c01189
|
|
13591
Saiki I, Yara M, Yamanaka T, Uchino H, Inazu M.
Functional Expression of Choline Transporter-Like Protein 1 in LNCaP Prostate Cancer Cells: A Novel Molecular Target
Biomol Ther (Seoul)
2020
28(2):195-201
PubMed ID: 31693854
DOI: 10.4062/biomolther.2019.097
|
|
13771
F. Sima, H. Kawano, A. Miyawaki, K. Obata, D. Serien, K. Sugioka
3D glass nanofluidics fabricated by femtosecond laser processing for study of cancer cell metastasis and invasion
SPIE LASE
2020
DOI: 10.1117/12.2547222
|
|
22124
Sima, F., Kawano, H., Hirano, M., Miyawaki, A., Obata, K., Serien, D., Sugioka, K.
Mimicking Intravasation–Extravasation with a 3D Glass Nanofluidic Model for the Chemotaxis‐Free Migration of Cancer Cells in Confined Spaces.
Adv Mater Technol
2020
5:2000484
DOI: 10.1002/admt.202000484
|
|
11271
Itoh A, Nonaka Y, Ogawa T, Nakamura T, Nishi N.
Galectin-9 induces atypical ubiquitination leading to cell death in PC-3 prostate cancer cells.
Glycobiology
2019
PubMed ID: 30383222
DOI: 10.1093/glycob/cwy099
|
|
11464
Ishigami-Yuasa M, Ekimoto H, Kagechika H.
Class IIb HDAC Inhibition Enhances the Inhibitory Effect of Am80, a Synthetic Retinoid, in Prostate Cancer.
Biol. Pharm. Bull.
2019
PubMed ID: 30828077
DOI: 10.1248/bpb.b18-00782
|
|
11507
Murata K, Saga R, Monzen S, Tsuruga E, Hasegawa K, Hosokawa Y.
Understanding the mechanism underlying the acquisition of radioresistance in human prostate cancer cells.
Oncol Lett
2019
PubMed ID: 31186811
DOI: 10.3892/ol.2019.10219
|
|
11639
Taniguchi K, Ii H, Kageyama S, Takagi H, Chano T, Kawauchi A, Nakata S.
Depletion of gamma-glutamylcyclotransferase inhibits cancer cell growth by activating the AMPK-FOXO3a-p21 axis.
Biochem. Biophys. Res. Commun.
2019
PubMed ID: 31345573
DOI: 10.1016/j.bbrc.2019.07.049
|
|
11800
Koizumi A, Narita S, Nakanishi H, Ishikawa M, Eguchi S, Kimura H, Takasuga S, Huang M, Inoue T, Sasaki J, Yoshioka T, Habuchi T, Sasaki T.
Increased fatty acyl saturation of phosphatidylinositol phosphates in prostate cancer progression.
Sci Rep
2019
PubMed ID: 31520002
DOI: 10.1038/s41598-019-49744-3
|
|
11807
Takagi H, Ii H, Kageyama S, Hanada E, Taniguchi K, Yoshiya T, Chano T, Kawauchi A, Nakata S.
Blockade of γ-Glutamylcyclotransferase Enhances Docetaxel Growth Inhibition of Prostate Cancer Cells.
Anticancer Res.
2019
PubMed ID: 31519583
DOI: 10.21873/anticanres.13666
|
|
11717
K Hayashi et al
Optimization of Surface Treatment of MEMS Probes for Single-cell Capture and Release
Sensors and Materials
2019
31(9):2873
DOI: 10.18494/SAM.2019.2322
|
|
13859
Park J, Komori T, Uda T, Miyajima K, Fujii T, Kim SH.
Sequential Cell-Processing System by Integrating Hydrodynamic Purification and Dielectrophoretic Trapping for Analyses of Suspended Cancer Cells
Micromachines (Basel)
2019
11(1):47
PubMed ID: 31905986
DOI: 10.3390/mi11010047
|
|
18197
Ii H, Yoshiya T, Nakata S, Taniguchi K, Hidaka K, Tsuda S, Mochizuki M, Nishiuchi Y, Tsuda Y, Ito K, Kageyama S, Yoshiki T.
A Novel Prodrug of a γ-Glutamylcyclotransferase Inhibitor Suppresses Cancer Cell Proliferation in vitro and Inhibits Tumor Growth in a Xenograft Mouse Model of Prostate Cancer
ChemMedChem
2018
13(2):155-163
PubMed ID: 29316360
DOI: 10.1002/cmdc.201700660
|
|
10845
Taniguchi K, Matsumura K, Ii H, Kageyama S, Ashihara E, Chano T, Kawauchi A, Yoshiki T, Nakata S.
Depletion of gamma-glutamylcyclotransferase in cancer cells induces autophagy followed by cellular senescence.
Am J Cancer Res
2018
8:650-661
PubMed ID: 29736310
|
|
11105
Senga S, Kobayashi N, Kawaguchi K, Ando A, Fujii H.
Fatty acid-binding protein 5 (FABP5) promotes lipolysis of lipid droplets, de novo fatty acid (FA) synthesis and activation of nuclear factor-kappa B (NF-κB) signaling in cancer cells.
Biochim Biophys Acta Mol Cell Biol Lipids
2018
1863(9):1057-1067
PubMed ID: 29906613
DOI: 10.1016/j.bbalip.2018.06.010
|
|
11160
Languon S, Tuffour I, Quayson EE, Appiah-Opong R, Quaye O.
In Vitro Evaluation of Cytotoxic Activities of Marketed Herbal Products in Ghana.
J Evid Based Integr Med
2018
PubMed ID: 30088418
DOI: 10.1177/2515690X18790723
|
|
4319
Liu Q, Wu Y, Seino H, Haga T, Yoshizawa T, Morohashi S, Kijima H.
Correlation between DEC1/DEC2 and epithelial‑mesenchymal transition in human prostate cancer PC‑3 cells.
Mol Med Rep
2018
PubMed ID: 30106153
DOI: 10.3892/mmr.2018.9367
|
|
14599
Senga S, Kawaguchi K, Kobayashi N, Ando A, Fujii H.
A novel fatty acid-binding protein 5-estrogen-related receptor α signaling pathway promotes cell growth and energy metabolism in prostate cancer cells
Oncotarget
2018
9(60):31753-31770
PubMed ID: 30167092
DOI: 10.18632/oncotarget.25878
|
|
7050
Kajiura K, Masuda K, Naruto T, Kohmoto T, Watabnabe M, Tsuboi M, Takizawa H, Kondo K, Tangoku A, Imoto I.
Frequent silencing of the candidate tumor suppressor TRIM58 by promoter methylation in early-stage lung adenocarcinoma.
Oncotarget
2017
8:2890-2905
PubMed ID: 27926516
DOI: 10.18632/oncotarget.13761
|
|
10506
Doi H, Kida T, Nishino K, Nakatsuji M, Sakamoto S, Shimizu S, Teraoka Y, Tamura Y, Kataoka Y, Inui T.
Solubility-Improved 10-O-Substituted SN-38 Derivatives with Antitumor Activity.
ChemMedChem
2017
12:1715-1722
PubMed ID: 28891271
DOI: 10.1002/cmdc.201700454
|
|
10973
Dynamics of Morphological Changes of Adherent Cultured Cells at a Range of Low Temperatures near Physiological Temperature (Time-Lapse Imaging by Digital Holographic Microscopy)
Cryobiology and Cryotechnology
2017
63, 45~51
DOI: 10.20585/cryobolcryotechnol.63.1_45
|
|
4534
Cui C, Hanyu M, Hatori A, Zhang Y, Xie L, Ohya T, Fukada M, Suzuki H, Nagatsu K, Jiang C, Luo R, Shao G, Zhang M, Wang F.
Synthesis and evaluation of [64Cu]PSMA-617 targeted for prostate-specific membrane antigen in prostate cancer.
Am J Nucl Med Mol Imaging
2017
7(2):40-52
PubMed ID: 28533936
|
|
14574
Shaoyi Chen, Stelios Florinas, Abigail Teitgen, Ze-Qi Xu, Changshou Gao, Herren Wu, Kazunori Kataoka, Horacio Cabral, R. James Christie
Controlled Fab installation onto polymeric micelle nanoparticles for tuned bioactivity
Science and Technology of Advanced Materials
2017
18:666-680
DOI: 10.1080/14686996.2017.1370361
|
|
9615
Ohya S, Kanatsuka S, Hatano N, Kito H, Matsui A, Fujimoto M, Matsuba S, Niwa S, Zhan P, Suzuki T, Muraki K.
Downregulation of the Ca(2+)-activated K(+) channel KC a3.1 by histone deacetylase inhibition in human breast cancer cells.
Pharmacol Res Perspect
2016
4:e00228
PubMed ID: 27069638
DOI: 10.1002/prp2.228
|
|
9862
Sakura Y, Tsuboi K, Uyama T, Zhang X, Taoka R, Sugimoto M, Kakehi Y, Ueda N.
A quantitative study on splice variants of N-acylethanolamine acid amidase in human prostate cancer cells and other cells.
Biochim. Biophys. Acta
2016
1861:1951-1958
PubMed ID: 27693242
DOI: 10.1016/j.bbalip.2016.09.018
|
|
10024
Matsumura K, Nakata S, Taniguchi K, Ii H, Ashihara E, Kageyama S, Kawauchi A, Yoshiki T.
Depletion of γ-glutamylcyclotransferase inhibits breast cancer cell growth via cellular senescence induction mediated by CDK inhibitor upregulation.
BMC Cancer
2016
16:748
PubMed ID: 27658708
DOI: 10.1186/s12885-016-2779-y
|
|
10908
Extracts of Codiaeum variegatum (L.) A. Juss is Cytotoxic on Human Leukemic, Breast and Prostate Cancer Cell Lines
Journal of Applied Pharmaceutical Science
2016
6, 087-093
DOI: 10.7324/JAPS.2016.601114
|
|
6034
Liu Q, Wu Y, Yoshizawa T, Yan X, Morohashi S, Seino H, Kato Y, Kijima H.
Basic helix-loop-helix transcription factor DEC2 functions as an anti-apoptotic factor during paclitaxel-induced apoptosis in human prostate cancer cells.
Int J Mol Med
2016
38(6):1727-1733
PubMed ID: 27840924
DOI: 10.3892/ijmm.2016.2798
|
|
12610
Zhang B, Shimada Y, Hirota T, Ariyoshi M, Kuroyanagi J, Nishimura Y, Tanaka T.
Novel immunologic tolerance of human cancer cell xenotransplants in zebrafish
Transl Res
2016
170:89-98.e3
PubMed ID: 26746804
DOI: 10.1016/j.trsl.2015.12.007
|
|
12621
Okada T, Uto K, Aoyagi T, Ebara M.
A biomimetic approach to hormone resistant prostate cancer cell isolation using inactivated Sendai virus (HVJ-E)
Biomater Sci
2016
4(1):96-103
PubMed ID: 26553555
DOI: 10.1039/c5bm00375j
|
|
12660
Thangavel S, Yoshitomi T, Sakharkar MK, Nagasaki Y.
Redox nanoparticle increases the chemotherapeutic efficiency of pioglitazone and suppresses its toxic side effects
Biomaterials
2016
99:109-23
PubMed ID: 27235996
DOI: 10.1016/j.biomaterials.2016.05.001
|
|
12452
Kim SH, Fujii T.
Efficient analysis of a small number of cancer cells at the single-cell level using an electroactive double-well array
Lab Chip
2016
16(13):2440-9
PubMed ID: 27189335
DOI: 10.1039/c6lc00241b
|
|
14141
Nara T, Narita S, Mingguo H, Yoshioka T, Koizumi A, Numakura K, Tsuruta H, Maeno A, Saito M, Inoue T, Tsuchiya N, Satoh S, Habuchi T.
Altered miRNA expression in high-fat diet-induced prostate cancer progression
Carcinogenesis
2016
37(12):1129-1137
PubMed ID: 27915273
DOI: 10.1093/carcin/bgw108
|
|
7447
Sakane C, Ohta H, Shidoji Y.
Measurement of lysine-specific demethylase-1 activity in the nuclear extracts by flow-injection based time-of-flight mass spectrometry.
J Clin Biochem Nutr
2015
56:123-31
PubMed ID: 25759518
DOI: 10.3164/jcbn.14-99
|
|
12866
Okada T, Niiyama E, Uto K, Aoyagi T, Ebara M.
Inactivated Sendai Virus (HVJ-E) Immobilized Electrospun Nanofiber for Cancer Therapy
Materials (Basel)
2015
9(1):12
PubMed ID: 28787810
DOI: 10.3390/ma9010012
|
|
14955
Nishikawa Y, Okuzaki D, Fukushima K, Mukai S, Ohno S, Ozaki Y, Yabuta N, Nojima H.
Withaferin A Induces Cell Death Selectively in Androgen-Independent Prostate Cancer Cells but Not in Normal Fibroblast Cells
PLoS One
2015
10(7):e0134137
PubMed ID: 26230090
DOI: 10.1371/journal.pone.0134137
|
|
15159
Honda S, Loher P, Shigematsu M, Palazzo JP, Suzuki R, Imoto I, Rigoutsos I, Kirino Y.
Sex hormone-dependent tRNA halves enhance cell proliferation in breast and prostate cancers
Proc Natl Acad Sci U S A
2015
112(29):E3816-25
PubMed ID: 26124144
DOI: 10.1073/pnas.1510077112
|
|
15240
Kobayashi M, Kim SH, Nakamura H, Kaneda S, Fujii T.
Cancer Cell Analyses at the Single Cell-Level Using Electroactive Microwell Array Device
PLoS One
2015
10(11):e0139980
PubMed ID: 26558904
DOI: 10.1371/journal.pone.0139980
|
|
18179
Chiba S, Ikushima H, Ueki H, Yanai H, Kimura Y, Hangai S, Nishio J, Negishi H, Tamura T, Saijo S, Iwakura Y, Taniguchi T.
Recognition of tumor cells by Dectin-1 orchestrates innate immune cells for anti-tumor responses
Elife
2014
3:e04177
PubMed ID: 25149452
DOI: 10.7554/eLife.04177
|
|
19249
Ito S, Ueda T, Ueno A, Nakagawa H, Taniguchi H, Hongo F, Kamoi K, Okihara K, Kawauchi A, Miki T.
Paired box 2 upregulates androgen receptor gene expression in androgen-independent prostate cancer
FEBS J
2014
281(19):4506-18
PubMed ID: 25132193
DOI: 10.1111/febs.12959
|
|
6398
Nagano K, Yamashita T, Inoue M, Higashisaka K, Yoshioka Y, Abe Y, Mukai Y, Kamada H, Tsutsumi Y, Tsunoda S
Eph receptor A10 has a potential as a target for a prostate cancer therapy.
Biochem Biophys Res Commun
2014
450(1):545-9
PubMed ID: 24924629
DOI: 10.1016/j.bbrc.2014.06.007
|
|
16006
Ramesh V, Ananda Rao B, Sharma P, Swarna B, Thummuri D, Srinivas K, Naidu VG, Jayathirtha Rao V.
Synthesis and biological evaluation of new rhodanine analogues bearing 2-chloroquinoline and benzo[h]quinoline scaffolds as anticancer agents
Eur J Med Chem
2014
83:569-80
PubMed ID: 24996143
DOI: 10.1016/j.ejmech.2014.06.013
|
|
19527
The apelin/APJ system induces maturation of the tumor vasculature and improves the efficiency of immune therapy
The apelin/APJ system induces maturation of the tumor vasculature and improves the efficiency of immune therapy
Oncogene
2012
31(27):3254-64
PubMed ID: 22037214
DOI: 10.1038/onc.2011.489
|
|
16648
Konishi J, Yamazaki K, Yokouchi H, Shinagawa N, Iwabuchi K, Nishimura M.
The characteristics of human NKT cells in lung cancer--CD1d independent cytotoxicity against lung cancer cells by NKT cells and decreased human NKT cell response in lung cancer patients
Hum Immunol
2004
65(11):1377-88
PubMed ID: 15556688
DOI: 10.1016/j.humimm.2004.09.003
|
|
5547
Orui H, Imaizumi S, Ogino T, Motoyama T.
Effects of bone morphogenetic protein-2 on human tumor cell growth and differentiation: a preliminary report.
J Orthop Sci
2000
5(6):600-4
PubMed ID: 11180925
DOI: 10.1007/s007760070012
|
Back
Top
CELL BANK Website
